Inhibition of differentiation by transforming growth factor ß1 in rhabdomyosarcoma cells
Tóm tắt
Từ khóa
Tài liệu tham khảo
Levy L, Hill CS. Alterations in components of the TGF-ß superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev 2006; 17: 41–58.
Liu D, Black BL, Derynck R. TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes 2001; 22: 2950–2966.
Olson EN. Interplay between proliferation and differentiation within the myogenic lineage. Development Biology 1992; 154: 261–272.
Dias P, Pharham DM, Shapiro DN, et el. Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: Diagnostic utility in rhabdomyosarcoma. Am J Pathol 1991; 137:1283–1291.
Parham DM. The molecular biology of childhood rhabdomyosarcoma. Semin Diagn Pathol 1994; 11: 39–46.
Wang H, Yang GH, Bu H, et al. Systematic analysis of the TGF-β/Smad signaling pathway in the rhabdomyosarcoma cell line RD. Int J Exp Path 2003; 84:153–163.
Ye L, Zhang HY, Wang H, et al. Effects of transforming growth factor beta1 on the growth of rhabdomyosarcoma cell line RD. Chin Med J 2005; 118: 678–686.
McAllister RM, MeInyk J, Finkelstein JZ, et al. Cultivation in vitro of cells derived from a human rhabdomyosarcoma. Cancer 1969; 24: 520–526.
Jason WB, Joe CW, Marieke M, et al. Differentiation of rhabdomyosarcoma cell lines using retinoic acid. Pediatr Blood Cancer 2006; 47: 733–784.
Stevens MCG. Treatment for childhood rhabdomyosarcoma: the cost of cure. Lancet Oncol 2005; 6: 77–84.
Xu Q, Wu Z. The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells. J Biol Chem 2000; 275: 36750–36757.
Ricaud S, Vernus B, Duclos M, at al. Inhibition of autocrine secretion of myostatin enhances terminal differentiation in human rhabdomyosarcoma cells. Oncogene 2003; 22: 8221–8232.
Okuno M, Kojima S, Matsushima-Nishiwaki R, et al. Retinoids in Cancer Chemoprevention Current Cancer Drug Targets 2004; 4: 285–298.
Hamade A, Deries M, Begemann G, et al. Retinoic acid activates myogenesis in vivo through Fgf8 signalling. Dev Biol 2006; 289:127–140.
Ricaud S, Vernus B, Bonnieu A, et al. Response of human rhabdomyosarcoma cell lines to retinoic acid: relationship with induction of differentiation and retinoic acid sensitivity. Exp Cell Res 2005; 311:192–204.
Sebire NJ, Malone M. Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas. J Clin Pathol 2003;56:412–416.
Kumar S, Perlman E, Harris CA et al. Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissue. Mod Pathol 2000;13:988–993.
Myer A, Olson EN, Klein WH. MyoD cannot compensate for the absence of myogenin during skeletal muscle differentiation in murine embryonic stem cells. Dev Biol 2001; 229:340–350.